Abstract:75 Objectives Parkinson disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) are all known to affect dopaminergic neurons and often present with similar clinical features. Dopamine transporter (DAT) imaging can demonstrate presynaptic dopaminergic neuronal loss in PD, MSA and PSP. However, differentiating atypical parkinsonism from PD is often difficult. In this study, we investigated differences in striatal subregional DAT loss in PD, MSA and PSP, as well as the diagnostic value of 11C-CFT PET imaging in the differential diagnosis of parkinsonism. Methods Brain 11C-CFT PET imaging was performed in 219 patients with parkinsonian disorders. The PET images were spatially normalized and a standardized set of regions of interest (ROIs) were defined bilaterally for the caudate, anterior putamen (AP), posterior putamen(PP), ventral putamen (VP), dorsal putamen (DP) and occipital cortex with ScAnVP software. The nondisplaceable binding potential (BPND; defined as the ratio of (striatum-occipital)/occipital radioactivity counts) of each striatal subregion and intersubregional ratio (ISR; defined as the ratio of the BPND of one subregion to that of another subregion) were calculated. After the imaging, these patients were assessed by blinded movement disorders specialists for a mean of 2.3 years before a final clinical diagnosis was made. The accuracy of DAT imaging-based classification was assessed by comparison with the final clinical diagnosis. Results 133 patients had a final clinical diagnosis of PD, 55 MSA, and 31 PSP with severity matched. The BPND of caudate in the PSP group was significantly lower than those in the PD and MSA groups. The ISR of each subregional putamen/caudate in the PSP group was significantly higher than those in the PD and MSA groups. At the cutoff value of 1.16, the AP/C ISR had 87%sensitivity and 93% specificity for differentiating PSP from PD. The classifications were also accurate for PP/C (0.63; 80% sensitivity, 88% specificity), VP/C (1.13; 87% sensitivity, 92% specificity) and DP/C (0.87; 87% sensitivity, 90% specificity) ISRs. At the cutoff value of 1.23, the AP/C ISR had 81% sensitivity and 87% specificity for differentiating PSP from MSA. The classifications were also accurate for PP/C (0.78; 68% sensitivity, 84% specificity), VP/C (1.15; 84% sensitivity, 86% specificity) and DP/C (0.98; 81% sensitivity, 82% specificity) ISRs. The BPND of DP and the ISRs of DP/non-DP subregions in the MSA group were significantly higher than those in the PD group. At the cutoff value of 0.81, the DP/AP ISR had 76% sensitivity and 82% specificity for differentiating MSA from PD. The classifications were also accurate for DP/C (0.76; 71% sensitivity, 75% specificity) and DP/VP (0.87; 76% sensitivity, 76% specificity) ISRs. Conclusions PD, MSA and PSP have different preferential subregional decreases in striatal DAT binding when examined by 11C-CFT PET imaging. The ISRs could provide valuable information to distinguish parkinsonian disorders, even in earlier stages of disease.

Dorsolateral putaminal abnormality on magnetic resonance imaging in differentiating parkinsonism-predominant multiple system atrophy from Parkinson's disease

The Putaminal Abnormalities on 3.0T Magnetic Resonance Imaging: Can They Separate Parkinsonism-Predominant Multiple System Atrophy from Parkinson's Disease?

The "Black Straight-Line Sign" in the Putamen in Diffusion-Weighted Imaging: A Potential Diagnostic MRI Marker for Multiple System Atrophy

MRI features of patients with multiple system atrophy and Parkinson's disease

Dopamine Transporter PET Imaging in Patients with Parkinson Variant of Multiple System Atrophy and Parkinson''s Disease

Morphology and signal changes of the lentiform nucleus based on susceptibility weighted imaging in parkinsonism-predominant multiple system atrophy

Interhemispheric synchrony differences between multiple system atrophy (Parkinsonian type) and Parkinson′s disease

Differentiation between Parkinson's Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle

In Vivo Cerebral Metabolic and Dopaminergic Characteristics in Multiple System Atrophy with Orthostatic Hypotension.

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease

T2*-weighted MRI in diagnosis of multiple system atrophy

Role of Neuropsychological Tests and Diffusion Tensor Imaging in the Differential Diagnosis of Multiple System Atrophy and Parkinson’s Disease

Interhemispheric Synchrony Differences Between Multiple System Atrophy (parkinsonian Type) and Parkinson's Disease

Differentiation of Cerebellum-Type and Parkinson-Type of Multiple System Atrophy by Using Multimodal MRI Parameters

Parkinson's disease or multiple system atrophy: potential separation by quantitative susceptibility mapping

Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping

Proton Magnetic Resonance Spectroscopy Study on Different Movement Disorder Subtypes of Idiopathic Parkinson's Disease

Subregional Patterns of Preferential Striatal DAT Loss Differ in PD, MSA and PSP

Different Iron-Deposition Patterns of Multiple System Atrophy with Predominant Parkinsonism and Idiopathetic Parkinson Diseases Demonstrated by Phase-Corrected Susceptibility-Weighted Imaging

Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type from Parkinson's Disease

Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.